珠江啤酒(002461.SZ):半年度淨利潤預增15%至25%
格隆匯7月10日丨珠江啤酒(002461.SZ)公佈2025年半年度業績預吿,1-6月公司實現歸屬於上市公司股東的淨利潤盈利5.75億元至6.25億元,比上年同期增長15%至25%;歸屬於上市公司股東的扣除非經常性損益後的淨利潤盈利5.47億元至5.95億元,比上年同期增長15%至25%;基本每股收益盈利0.2597元/股至0.2823元/股。
報吿期,公司高質量發展步伐更加穩健,產品結構持續優化,實現啤酒銷量和營業收入同比增長,預計歸屬於上市公司股東的淨利潤比上年同期增長15%至25%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.